Following the company’s most recent acquisition, Haywood analyst Neal Gilmer has maintained hi... Read More
Following the company’s third quarter results, Haywood analyst Neal Gilmer has maintained his ... Read More
Following the company’s Q1,2024 results, Haywood Capital Markets analyst Neal Gilmer has maint... Read More
Following a major investment into the company, Haywood analyst Neil Gilmer has upgraded Organigram (... Read More
The market may not be favouring cannabis name Organigram Holdings (Organigram Stock Quote, Charts, N... Read More
The outlook for the next few quarters is a little dimmer for Canadian cannabis licensed producer Org... Read More
After quarterly earnings, Eight Capital analyst Ty Collin is staying on the sidelines on Canadian ca... Read More
Calling it one of Canada’s best-run cannabis operations, Raymond James analyst Michael W. Freeman ... Read More
Continuing market share gains in Canada’s cannabis trade look good on Moncton, New Brunswick-based... Read More
It’s still an emerging market but signs are pointing to a slowdown in Canadian cannabis, according... Read More
Investors interested in the Canadian cannabis market should be thinking about Organigram Holdings (O... Read More
Strong quarterly financials are keeping ATB Capital Markets analyst Frederico Gomes in a bullish fra... Read More
ATB Capital Markets analyst Frederico Gomes is still cautious about Organigram Holdings (Organigram... Read More
ATB Capital Markets analyst Frederico Gomes is staying neutral on Organigram Holdings Inc. (Organig... Read More
Haywood Capital Markets analyst Neal Gilmer has slightly altered his outlook on Organigram HoldingsÂ... Read More
Raymond James analyst Rahul Sarugaser holds an optimistic view of Organigram Holdings Inc. (Organigr... Read More
After such a promising start to the year it’s safe to say that 2021 has been a bust for Canadian c... Read More
Raymond James analyst Rahul Sarugaser remains optimistic about Organigram Holdings Inc. (Organigram ... Read More
Share
Tweet
pin
Share